|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 5/071 | |
| C12N 5/079 | |||
| C07K 14/78 |
| (11) | Patento numeris | 3400287 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17704327.0 |
| Europos patento paraiškos padavimo data | 2017-01-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-11-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-12-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/012061 |
| Data | 2017-01-03 |
| (87) | Numeris | WO 2017/120147 |
| Data | 2017-07-13 |
| (30) | Numeris | Data | Šalis |
| 201662274700 P | 2016-01-04 | US | |
| 201662414533 P | 2016-10-28 | US |
| (72) |
SIPRASHVILI, Zurab, US
NGUYEN, Ngon T., US
MARINKOVICH, M. Peter, US
TANG, Jean, US
LANE, Alfred T., US
KHAVARI, Paul A., US
|
| (73) |
The Board of Trustees of the Leland Stanford Junior University,
Office of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386, Stanford, CA 94305-2038,
US
U.S. Government as represented by the Department of Veterans Affairs, 810 Vermont Avenue, Washington, DC 20420, US |
| (54) | GENE THERAPY FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA USING GENETICALLY CORRECTED AUTOLOGOUS KERATINOCYTES |
| GENE THERAPY FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA USING GENETICALLY CORRECTED AUTOLOGOUS KERATINOCYTES |